Role of Tonsillectomy in PFAPA Syndrome

Kevin K Wong1, Jane C Finlay, J Paul Moxham

  • 1Department of Surgery and Infectious , British Columbia's Children's Hospital, Vancouver, British Columbia, Canada.

Insights

Tonsillectomy effectively treats children with periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome, leading to symptom remission and preventing recurrences. This surgical intervention offers a viable solution for managing PFAPA syndrome.

Area of Science:

  • Pediatric Otolaryngology
  • Pediatric Allergy and Immunology
  • Pediatric Infectious Diseases

Background:

  • Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome is a common autoinflammatory disorder in children.
  • Recurrent episodes of fever, stomatitis, pharyngitis, and adenitis significantly impact children's quality of life.
  • Current management strategies for PFAPA syndrome vary, with limited evidence on long-term efficacy.

Purpose of the Study:

  • To evaluate the effectiveness of tonsillectomy in resolving symptoms of PFAPA syndrome.
  • To assess the rate of symptom recurrence after tonsillectomy in pediatric patients.
  • To determine the safety and complication profile of tonsillectomy for PFAPA syndrome.

Main Methods:

  • Retrospective case series design.
  • Study conducted at a tertiary care children's hospital.
  • Analysis of patients diagnosed with PFAPA syndrome between 2000 and 2004.

Main Results:

  • Complete remission of PFAPA syndrome symptoms was achieved in 8 out of 9 patients within 3 months post-tonsillectomy.
  • The remaining patient experienced a significant reduction in episode frequency, with eventual symptom resolution at 2 years.
  • No adverse complications were reported following the tonsillectomy procedure.

Conclusions:

  • Tonsillectomy demonstrates high efficacy in achieving symptom resolution for pediatric PFAPA syndrome.
  • The surgical procedure is associated with a low risk of complications.
  • Tonsillectomy represents a viable and effective treatment option for children diagnosed with PFAPA syndrome.
Abstract

Related Concept Videos

Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...